We have previously shown that BRAF mutant/MSS cancers have a comparable rate of p53 mutation to BRAF wild type/MSS cancers, and this was significantly greater than the p53 mutation rate found in BRAF mutant/MSI cancers. Here, TP53 is linked to cancer.